This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 24/12/2277    most recent 01.ATV.0000147766.68987.0dv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, L. Articles by Freedman, N. J. Search for Related Content PubMed PubMed Citation Articles by Zhang, L. Articles by Freedman, N. J. Pubmed/NCBI databases Substance via MeSH Related Collections Animal models of human disease Cell signalling/signal transduction Genetically altered mice Smooth muscle proliferation and differentiation Mechanism of atherosclerosis/growth factors Other Vascular biology

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:2277.)
© 2004 American Heart Association, Inc.

Vascular Biology

Vein Graft Neointimal Hyperplasia Is Exacerbated by Tumor Necrosis Factor Receptor-1 Signaling in Graft-Intrinsic Cells

Lisheng Zhang; Karsten Peppel; Leigh Brian; Lynn Chien; Neil J. Freedman

From Duke University Department of Medicine (Cardiology), Duke University Medical Center, Durham, NC.

Correspondence to Karsten Peppel or Neil J. Freedman, Box 3187, Duke University Medical Center, Durham, NC 27710. E-mail karsten.peppel{at}duke.edu or neil.freedman@duke.edu

Objective— Vein graft remodeling and neointimal hyperplasia involve inflammation, graft-intrinsic cells, and recruitment of vascular progenitor cells. We sought to examine if the inflammatory cytokine tumor necrosis factor (TNF) affects vein graft remodeling via its p55 TNF receptor-1 (p55).

Methods and Results— Inferior vena cava-to-carotid artery interposition grafting was performed between p55^–/– and congenic (C57Bl/6) wild-type (WT) mice. Immunofluorescence revealed TNF in early (2-week) vein grafts. Six weeks postoperatively, luminal and medial areas were indistinguishable among all vein graft groups. However, neointimal area was reduced in p55^–/– grafts: by 40% in p55^–/– grafts placed in p55^–/– recipients, and by 21% in p55^–/– grafts placed in WT recipients, compared with WT grafts in WT recipients (P<0.05). In 2-week-old vein grafts, p55 deficiency reduced intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and monocyte chemoattractant protein-1 expression by 50% to 60%, and increased the extent of graft endothelialization. In vitro, TNF promoted chemokine expression and [³H]thymidine incorporation in vascular smooth muscle cells (SMCs) from WT, but not from p55^–/– mice. However, responses of WT and p55^–/– SMCs to other growth factors were equivalent.

Conclusions— Signaling via p55, in vein graft-intrinsic cells, contributes to the pathogenesis of vein graft neointimal hyperplasia.

In surgical mouse chimeras, TNF receptor-1 (p55)-deficient vein grafts (compared with WT grafts) demonstrated less ICAM-1, VCAM-1, and MCP-1 expression, accelerated endothelialization, and reduced neointimal hyperplasia. However, vein graft medial thickness was unaffected. SMC chemokine expression and DNA synthesis in response to TNF, but not PDGF, was abrogated by p55 deficiency.

Key Words: vascular remodeling • inflammation • mouse models • smooth muscle cells • tumor necrosis factor

This article has been cited by other articles:

				S.-A. Hassantash, B. Bikdeli, S. Kalantarian, M. Sadeghian, and H. Afshar Pathophysiology of Aortocoronary Saphenous Vein Bypass Graft Disease Asian Cardiovasc Thorac Ann, August 1, 2008; 16(4): 331 - 336. [Abstract] [Full Text] [PDF]

				L. Zhang, P. Sivashanmugam, J.-H. Wu, L. Brian, S. T. Exum, N. J. Freedman, and K. Peppel Tumor Necrosis Factor Receptor-2 Signaling Attenuates Vein Graft Neointima Formation by Promoting Endothelial Recovery Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): 284 - 289. [Abstract] [Full Text] [PDF]

				P. H. Giangrande, J. Zhang, A. Tanner, A. D. Eckhart, R. E. Rempel, E. R. Andrechek, J. M. Layzer, J. R. Keys, P.-O. Hagen, J. R. Nevins, et al. Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia PNAS, August 7, 2007; 104(32): 12988 - 12993. [Abstract] [Full Text] [PDF]

				L. Zhang, K. Peppel, P. Sivashanmugam, E. S. Orman, L. Brian, S. T. Exum, and N. J. Freedman Expression of Tumor Necrosis Factor Receptor-1 in Arterial Wall Cells Promotes Atherosclerosis Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1087 - 1094. [Abstract] [Full Text] [PDF]

				J.-H. Wu, R. Goswami, X. Cai, S. T. Exum, X. Huang, L. Zhang, L. Brian, R. T. Premont, K. Peppel, and N. J. Freedman Regulation of the Platelet-derived Growth Factor Receptor-beta by G Protein-coupled Receptor Kinase-5 in Vascular Smooth Muscle Cells Involves the Phosphatase Shp2 J. Biol. Chem., December 8, 2006; 281(49): 37758 - 37772. [Abstract] [Full Text] [PDF]

				S. P. Salzberg, F. Filsoufi, A. Anyanwu, K. von Harbou, E. Karlof, A. Carpentier, H. M. Dansky, and D. H. Adams Increased Neointimal Formation After Surgical Vein Grafting in a Murine Model of Type 2 Diabetes Circulation, July 4, 2006; 114(1_suppl): I-302 - I-307. [Abstract] [Full Text] [PDF]

				E. W. Raines and N. Ferri Thematic Review Series: The Immune System and Atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease J. Lipid Res., June 1, 2005; 46(6): 1081 - 1092. [Abstract] [Full Text] [PDF]